Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

DRUG ADVANCES

EXCEPTIONAL CASE REPORT

STIMULUS REPORTS

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSFUSION MEDICINE

TRANSPLANTATION

Yoshihiro Inamoto,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Tomohiro Matsuda,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Ken Tabuchi,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Saiko Kurosawa,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Hideki Nakasone,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Hisakazu Nishimori,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Satoshi Yamasaki,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Noriko Doki,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Koji Iwato,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Takehiko Mori,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Satoshi Takahashi,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Hiromasa Yabe,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Akio Kohno,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Hirohisa Nakamae,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Toru Sakura,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Hisako Hashimoto,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Junichi Sugita,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Hiroatsu Ago,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Takahiro Fukuda,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Tatsuo Ichinohe,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Yoshiko Atsuta,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group,Takuya Yamashita,on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group

ERRATA

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals